A new journal affiliated with the Great Wall-International Congress of Cardiology.

Related StoriesMelatonin hormone can help prevent cardiovascular disease risk in kids born through ARTMeta-analysis works with that intake of tree nuts lowers risk of cardiovascular diseaseResverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015Professor Dayi Hu writes: 'It is evident that China today needs its own English-language, multi-national journal where top-rated articles from around the global world could be published.Vasogen is currently conducting the two 2,000-patient pivotal stage III ACCLAIM trial in chronic heart failure patients, which is made to support regulatory approvals and the commercial intro of Celacade in North America and Europe. ACCLAIM will further measure the influence of Celacade on reducing mortality and morbidity in this patient population. Dr. Little, Chairman, Division of Medicine at The Cleveland Clinic Basis, may be the Chairman of the Steering Committee and Global Principal Investigator for the ACCLAIM trial.